NCT01421251View on ClinicalTrials.gov

H1N1 Vaccine Safety in Manitoba, Canada

UnknownOBSERVATIONAL
Enrollment

800,000

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
H1N1 Influenza
Trial Locations (1)

R3B 3P5

International Centre for Infectious Diseases, Winnipeg

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

International Centre for Infectious Diseases, Canada

OTHER

NCT01421251 - H1N1 Vaccine Safety in Manitoba, Canada | Biotech Hunter | Biotech Hunter